Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ACAD ACADIA Pharmaceuticals	$20.98 -4.9%	$20.81	$13.40 ▼ $25.23	$3.51B	0.64	1.98 million shs	2.08 million shs
ACC American Campus Communities	$65.42	$65.24	$48.01 ▼ $65.46	$9.12B	0.75	2.52 million shs	18.86 million shs
FLGT Fulgent Genetics	$19.27 -1.4%	$20.23	$14.57 ▼ $25.11	$586.66M	1.03	287,024 shs	203,031 shs
JNJ Johnson & Johnson	$156.87 -0.5%	$153.73	$140.68 ▼ $169.99	$377.44B	0.41	8.06 million shs	7.87 million shs
SBNY Signature Bank	$0.68	$0.71	$0.01 ▼ $2.48	$42.79M	10.92	60,438 shs	20,057 shs
SMCI Super Micro Computer	$49.24 -2.2%	$42.60	$17.25 ▼ $96.33	$29.39B	1.43	68.54 million shs	24.81 million shs
XRAY DENTSPLY SIRONA	$16.21 -2.5%	$15.90	$12.16 ▼ $27.95	$3.23B	0.94	2.92 million shs	1.21 million shs

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ACAD ACADIA Pharmaceuticals	+2.27%	+5.30%	-0.63%	+51.30%	+28.93%
ACC American Campus Communities	0.00%	0.00%	0.00%	0.00%	0.00%
FLGT Fulgent Genetics	-0.15%	-2.54%	-10.24%	+2.89%	-0.26%
JNJ Johnson & Johnson	+1.05%	+1.16%	+0.81%	+4.02%	+5.56%
SBNY Signature Bank	0.00%	-6.21%	-20.00%	+1.49%	-65.13%
SMCI Super Micro Computer	+0.68%	+3.82%	+17.36%	+51.92%	-44.04%
XRAY DENTSPLY SIRONA	+0.30%	+0.51%	+1.28%	+30.15%	-31.91%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ACAD ACADIA Pharmaceuticals	4.6317 of 5 stars	4.4	3.0	0.0	0.0	2.7	4.2	2.5
ACC American Campus Communities	0.5276 of 5 stars	0.0	0.0	0.0	3.5	0.0	1.7	0.6
FLGT Fulgent Genetics	3.6093 of 5 stars	2.3	1.0	0.0	4.1	2.7	3.3	0.6
JNJ Johnson & Johnson	4.7715 of 5 stars	2.3	4.0	4.2	3.9	3.0	1.7	1.9
SBNY Signature Bank	0.3464 of 5 stars	0.0	1.0	0.0	2.6	1.1	0.0	0.0
SMCI Super Micro Computer	4.2199 of 5 stars	2.2	2.0	0.0	2.4	3.5	3.3	2.5
XRAY DENTSPLY SIRONA	4.5705 of 5 stars	3.1	3.0	4.2	3.8	2.1	1.7	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ACAD ACADIA Pharmaceuticals	2.71	Moderate Buy	$27.88	32.86% Upside
ACC American Campus Communities	0.00	N/A	N/A	N/A
FLGT Fulgent Genetics	2.50	Moderate Buy	$24.00	24.55% Upside
JNJ Johnson & Johnson	2.55	Moderate Buy	$171.00	9.01% Upside
SBNY Signature Bank	0.00	N/A	N/A	N/A
SMCI Super Micro Computer	2.33	Hold	$41.47	-15.79% Downside
XRAY DENTSPLY SIRONA	2.15	Hold	$20.36	25.62% Upside

Current Analyst Ratings Breakdown

Latest SMCI, FLGT, XRAY, ACC, ACAD, JNJ, and SBNY Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/11/2025	SMCI Super Micro Computer	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$37.00 ➝ $52.00
7/10/2025	JNJ Johnson & Johnson	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Underperform ➝ Underperform
7/10/2025	JNJ Johnson & Johnson	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$169.00 ➝ $171.00
7/9/2025	SMCI Super Micro Computer	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Underperform	$35.00
7/3/2025	SMCI Super Micro Computer	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$40.00 ➝ $47.00
6/26/2025	ACAD ACADIA Pharmaceuticals	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Perform ➝ Market Perform	$19.00 ➝ $22.00
6/26/2025	ACAD ACADIA Pharmaceuticals	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Outperform ➝ Market Outperform	$37.00
6/26/2025	ACAD ACADIA Pharmaceuticals	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$30.00
6/26/2025	ACAD ACADIA Pharmaceuticals	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$32.00
6/25/2025	SMCI Super Micro Computer	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform ➝ Outperform
6/25/2025	SMCI Super Micro Computer	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy

(Data available from 7/11/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ACAD ACADIA Pharmaceuticals	$957.80M	3.67	$0.69 per share	30.60	$4.40 per share	4.77
ACC American Campus Communities	$942.41M	9.68	$2.28 per share	28.64	$23.34 per share	2.80
FLGT Fulgent Genetics	$292.45M	2.01	N/A	N/A	$36.92 per share	0.52
JNJ Johnson & Johnson	$89.33B	4.23	$13.17 per share	11.91	$29.69 per share	5.28
SBNY Signature Bank	$2.70B	0.02	$17.00 per share	0.04	N/A	∞
SMCI Super Micro Computer	$14.94B	1.97	$2.20 per share	22.40	$9.69 per share	5.08
XRAY DENTSPLY SIRONA	$3.72B	0.87	$7.20 per share	2.25	$9.77 per share	1.66

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ACAD ACADIA Pharmaceuticals	$226.45M	$1.37	15.31	27.61	4.65	22.97%	17.46%	10.75%	8/5/2025 (Estimated)
ACC American Campus Communities	$35.49M	$0.50	130.84	24.69	N/A	7.14%	2.21%	0.94%	N/A
FLGT Fulgent Genetics	-$42.71M	-$1.33	N/A	N/A	N/A	-13.94%	-2.19%	-2.02%	8/1/2025 (Estimated)
JNJ Johnson & Johnson	$14.07B	$8.99	17.45	14.17	2.36	24.42%	33.46%	13.30%	7/16/2025 (Estimated)
SBNY Signature Bank	$1.34B	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
SMCI Super Micro Computer	$1.15B	$1.90	25.90	22.18	N/A	5.61%	20.41%	11.86%	8/5/2025 (Estimated)
XRAY DENTSPLY SIRONA	-$910M	-$4.54	N/A	8.53	1.18	-24.42%	14.31%	5.37%	7/30/2025 (Estimated)

Latest SMCI, FLGT, XRAY, ACC, ACAD, JNJ, and SBNY Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/5/2025	Q2 2025	ACAD ACADIA Pharmaceuticals	$0.14	N/A	N/A	N/A	$263.07 million	N/A
8/5/2025	Q4 2025	SMCI Super Micro Computer	$0.44	N/A	N/A	N/A	$5.88 billion	N/A
8/1/2025	Q2 2025	FLGT Fulgent Genetics	-$0.23	N/A	N/A	N/A	$76.21 million	N/A
7/30/2025	Q2 2025	XRAY DENTSPLY SIRONA	$0.50	N/A	N/A	N/A	$929.67 million	N/A
7/16/2025	Q2 2025	JNJ Johnson & Johnson	$2.65	N/A	N/A	N/A	$22.85 billion	N/A
5/8/2025	Q1 2025	XRAY DENTSPLY SIRONA	$0.29	$0.43	+$0.14	$0.10	$854.75 million	$879.00 million
5/7/2025	Q1 2025	ACAD ACADIA Pharmaceuticals	$0.10	$0.11	+$0.01	$0.11	$239.32 million	$244.32 million
5/6/2025	Q3 2025	SMCI Super Micro Computer	$0.30	$0.31	+$0.01	$0.17	$5.40 billion	$4.60 billion
5/2/2025	Q1 2025	FLGT Fulgent Genetics	-$0.18	$0.04	+$0.22	-$0.37	$71.26 million	$73.46 million
4/15/2025	Q1 2025	JNJ Johnson & Johnson	$2.59	$2.77	+$0.18	$4.54	$21.65 billion	$21.89 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ACAD ACADIA Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
ACC American Campus Communities	N/A	N/A	N/A	N/A	N/A
FLGT Fulgent Genetics	N/A	N/A	N/A	N/A	N/A
JNJ Johnson & Johnson	$5.20	3.31%	N/A	57.84%	64 Years
SBNY Signature Bank	$0.70	102.94%	N/A	N/A	N/A
SMCI Super Micro Computer	N/A	N/A	N/A	N/A	N/A
XRAY DENTSPLY SIRONA	$0.64	3.95%	N/A	N/A	13 Years

Latest SMCI, FLGT, XRAY, ACC, ACAD, JNJ, and SBNY Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/21/2025	XRAY DENTSPLY SIRONA	quarterly	$0.16	3.92%	6/27/2025	6/27/2025	7/11/2025
4/15/2025	JNJ Johnson & Johnson	quarterly	$1.30	3.37%	5/27/2025	5/27/2025	6/10/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ACAD ACADIA Pharmaceuticals	N/A	2.88	2.80
ACC American Campus Communities	1.06	1.02	2.18
FLGT Fulgent Genetics	N/A	6.32	6.32
JNJ Johnson & Johnson	0.49	1.26	1.03
SBNY Signature Bank	N/A	N/A	N/A
SMCI Super Micro Computer	0.38	6.66	3.95
XRAY DENTSPLY SIRONA	0.79	1.10	0.76

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ACAD ACADIA Pharmaceuticals	96.71%
ACC American Campus Communities	97.27%
FLGT Fulgent Genetics	48.06%
JNJ Johnson & Johnson	69.55%
SBNY Signature Bank	11.07%
SMCI Super Micro Computer	84.06%
XRAY DENTSPLY SIRONA	95.70%

Insider Ownership

Company	Insider Ownership
ACAD ACADIA Pharmaceuticals	26.50%
ACC American Campus Communities	0.92%
FLGT Fulgent Genetics	31.76%
JNJ Johnson & Johnson	0.16%
SBNY Signature Bank	1.50%
SMCI Super Micro Computer	17.60%
XRAY DENTSPLY SIRONA	0.50%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ACAD ACADIA Pharmaceuticals	510	167.36 million	123.01 million	Optionable
ACC American Campus Communities	3,006	139.48 million	138.20 million	Optionable
FLGT Fulgent Genetics	1,313	30.44 million	20.78 million	Optionable
JNJ Johnson & Johnson	138,100	2.41 billion	2.40 billion	Optionable
SBNY Signature Bank	2,240	62.93 million	N/A	No Data
SMCI Super Micro Computer	5,684	596.82 million	491.78 million	Optionable
XRAY DENTSPLY SIRONA	14,000	199.29 million	198.30 million	Optionable

SMCI, FLGT, XRAY, ACC, ACAD, JNJ, and SBNY Headlines

Recent News About These Companies

Dentsply Sirona to Host Second Quarter Conference Call on August 7th

July 10 at 8:30 AM | globenewswire.com

Why Dentsply International (XRAY) is a Top Momentum Stock for the Long-Term

July 9 at 10:50 AM | zacks.com

Analysts Set DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Target Price at $20.36

July 7, 2025 | americanbankingnews.com

DENTSPLY SIRONA (NASDAQ:XRAY) Downgraded by Wall Street Zen to Hold

July 6, 2025 | americanbankingnews.com

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Sold by VELA Investment Management LLC

July 5, 2025 | marketbeat.com

DENTSPLY SIRONA (NASDAQ:XRAY) Downgraded by Wall Street Zen to "Hold"

July 5, 2025 | marketbeat.com

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Average Rating of "Hold" from Analysts

July 4, 2025 | marketbeat.com

Why Dentsply International (XRAY) is a Top Value Stock for the Long-Term

July 3, 2025 | zacks.com

Wealth Enhancement Advisory Services LLC Purchases 15,117 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

July 3, 2025 | marketbeat.com

XRAY or MMSI: Which Is the Better Value Stock Right Now?

July 2, 2025 | zacks.com

Is Dentsply Sirona (XRAY) Stock Undervalued Right Now?

July 2, 2025 | zacks.com

Janney Montgomery Scott LLC Raises Stock Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

June 30, 2025 | marketbeat.com

The Top 5 Analyst Questions From Dentsply Sirona’s Q1 Earnings Call

June 27, 2025 | msn.com

Canvas Wealth Advisors LLC Has $4 Million Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

June 27, 2025 | marketbeat.com

Lecap Asset Management Ltd. Makes New Investment in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

June 26, 2025 | marketbeat.com

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Dentsply Sirona Inc. (XRAY) and Encourages Shareholders to Learn More About the Investigation

June 17, 2025 | accessnewswire.comA

XRAY vs. MMSI: Which Stock Is the Better Value Option?

June 16, 2025 | zacks.com

Should Value Investors Buy Dentsply Sirona (XRAY) Stock?

June 16, 2025 | zacks.com

Dentsply Sirona Inc. (XRAY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

June 15, 2025 | accessnewswire.comA

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Bought by Sound Income Strategies LLC

June 15, 2025 | marketbeat.com

GAMMA Investing LLC Acquires 92,994 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

June 15, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Intel's Turnaround Strategy Shifts From Planning to Attack Mode
By Jeffrey Neal Johnson | June 20, 2025
View Intel's Turnaround Strategy Shifts From Planning to Attack Mode
3 AI Infrastructure Stocks With Strong Growth, Not Hype
By Chris Markoch | June 26, 2025
View 3 AI Infrastructure Stocks With Strong Growth, Not Hype
3 Catalysts in 7 Days: Archer's Growth Story Just Accelerated
By Jeffrey Neal Johnson | June 18, 2025
View 3 Catalysts in 7 Days: Archer's Growth Story Just Accelerated
AMD Accelerates Stack Development: Share Price to Follow
By Thomas Hughes | June 16, 2025
View AMD Accelerates Stack Development: Share Price to Follow
Oracle Stock Boils Higher, $300 Price Target in Sight
By Thomas Hughes | June 25, 2025
View Oracle Stock Boils Higher, $300 Price Target in Sight

SMCI, FLGT, XRAY, ACC, ACAD, JNJ, and SBNY Company Descriptions

ACADIA Pharmaceuticals NASDAQ:ACAD

$20.98 -1.08 (-4.90%)

Closing price 04:00 PM Eastern

Extended Trading

$21.35 +0.37 (+1.76%)

As of 06:20 PM Eastern

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization innovative medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases in the United States. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis; and DAYBUE, a novel synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 for treatment of Rett Syndrome. It also develops Pimavanserin that is in Phase III ADVANCE-2 study to treat the negative symptoms of schizophrenia; ACP-101 whixh is in Phase III for the treatment of hyperphagia in Prader-Willi syndrome; ACP-204 which is in Phase II for the treatment of Alzheimer's disease psychosis; ACP-2591 that is in Phase I for Rett syndrome and Fragile X syndrome; preclinical antisense oligonucleotide programs; and other programs for neuropsychiatric symptoms. It has a license agreement with Neuren Pharmaceuticals Limited to develop and commercialize trofinetide for Rett syndrome and other indications; and a license and collaboration agreement with Stoke Therapeutics, Inc. to discover, develop and commercialize novel RNA-based medicines for the potential treatment of severe and rare genetic neurodevelopmental diseases of the CNS. The company was formerly known as Receptor Technologies, Inc. and changed its name ACADIA Pharmaceuticals Inc. in 1997. ACADIA Pharmaceuticals Inc. was incorporated in 1993 and is headquartered in San Diego, California.

American Campus Communities NYSE:ACC

American Campus Communities, Inc. is the largest owner, manager and developer of high-quality student housing communities in the United States. The company is a fully integrated, self-managed and self-administered equity real estate investment trust (REIT) with expertise in the design, finance, development, construction management and operational management of student housing properties. As of September 30, 2020, American Campus Communities owned 166 student housing properties containing approximately 111,900 beds. Including its owned and third-party managed properties, ACC's total managed portfolio consisted of 204 properties with approximately 139,900 beds.

Fulgent Genetics NASDAQ:FLGT

$19.27 -0.28 (-1.43%)

Closing price 04:00 PM Eastern

Extended Trading

$19.28 +0.02 (+0.08%)

As of 04:53 PM Eastern

Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in El Monte, California.

Johnson & Johnson NYSE:JNJ

$156.87 -0.82 (-0.52%)

Closing price 03:59 PM Eastern

Extended Trading

$157.26 +0.38 (+0.25%)

As of 06:31 PM Eastern

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Signature Bank NASDAQ:SBNY

$0.68 0.00 (0.00%)

As of 03:50 PM Eastern

As of March 12, 2023, Signature Bank went out of business. Previously, the company provided digital assets banking services and comprised of certain loan portfolios. The company was incorporated in 2000 and is based in New York, New York. Signature Bank now trades on OTCPK.

Super Micro Computer NASDAQ:SMCI

$49.24 -1.12 (-2.22%)

Closing price 04:00 PM Eastern

Extended Trading

$49.22 -0.02 (-0.03%)

As of 06:31 PM Eastern

Super Micro Computer, Inc., together with its subsidiaries, develops and manufactures high performance server and storage solutions based on modular and open architecture in the United States, Europe, Asia, and internationally. Its solutions range from complete server, storage systems, modular blade servers, blades, workstations, full racks, networking devices, server sub-systems, server management software, and security software. The company provides application-optimized server solutions, rackmount and blade servers, storage, and subsystems and accessories; and server software management solutions, such as Server Management Suite, including Supermicro Server Manager, Supermicro Power Management software, Supermicro Update Manager, SuperCloud Composer, and SuperDoctor 5. In addition, it offers server subsystems and accessories comprising server boards, chassis, power supplies, and other accessories. Further, the company provides server and storage system integration, configuration, and software upgrade and update services; and technical documentation services, as well as identifies service requirements, creates and executes project plans, and conducts verification testing and technical documentation, and training services. Additionally, it offers help desk and on-site product support services for its server and storage systems; and customer support services, including ongoing maintenance and technical support for its products. The company provides its products to enterprise data centers, cloud computing, artificial intelligence, and 5G and edge computing markets. It sells its products through direct and indirect sales force, distributors, value-added resellers, system integrators, and original equipment manufacturers. The company was incorporated in 1993 and is headquartered in San Jose, California.

DENTSPLY SIRONA NASDAQ:XRAY

$16.21 -0.41 (-2.47%)

Closing price 04:00 PM Eastern

Extended Trading

$16.39 +0.18 (+1.08%)

As of 06:30 PM Eastern

DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform. It also provides endodontic products consisting of motorized endodontic handpieces, files, sealers, irrigation needles, and other tools that support root canal procedures; restorative products, including dental ceramics, crowns, and veneers; and preventative products, such as curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, and impression materials. In addition, the company offers SureSmile and Byte aligner solutions; VPro/HyperByte, a high-frequency vibration technology device; SureSmile Simulator, which creates a 3D visualization of a patient's outcome; and Byte Plus for treatment planning. Further, it provides dental implants, digital dentures, crown and bridge porcelain products, bone regenerative and restorative solutions, treatment planning software, and educational programs; dental prosthetics; urology catheters; and other health-related consumables. The company serves professional dental and consumable medical device markets through third-party distributors. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare MarketRank™

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SMCI, FLGT, XRAY, ACC, ACAD, JNJ, and SBNY Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SMCI, FLGT, XRAY, ACC, ACAD, JNJ, and SBNY Earnings

Compare Dividends

Latest SMCI, FLGT, XRAY, ACC, ACAD, JNJ, and SBNY Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SMCI, FLGT, XRAY, ACC, ACAD, JNJ, and SBNY Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

SMCI, FLGT, XRAY, ACC, ACAD, JNJ, and SBNY Company Descriptions

ACADIA Pharmaceuticals NASDAQ:ACAD

American Campus Communities NYSE:ACC

Fulgent Genetics NASDAQ:FLGT

Johnson & Johnson NYSE:JNJ

Signature Bank NASDAQ:SBNY

Super Micro Computer NASDAQ:SMCI

DENTSPLY SIRONA NASDAQ:XRAY

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools